Intravenous Plasma Treatment for Parkinson's Disease

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

September 24, 2018

Primary Completion Date

August 7, 2019

Study Completion Date

August 8, 2019

Conditions
Idiopathic Parkinson Disease
Interventions
BIOLOGICAL

[21CFR640.30] Plasma from 18 - 25 year old volunteer donors

12.5 ml/kg intravenous Spectrum Plasma yFFP, per each of two infusions (25 ml/kg total), in combination with ongoing normal standard treatment.

OTHER

Saline

12.5 ml/kg intravenous 0.9% sodium chloride with 0.1% riboflavin , per each of two infusions (25 ml/kg total), in combination with ongoing normal standard treatment.

Trial Locations (1)

77030

The Neurology Center, Houston

All Listed Sponsors
collaborator

Carolina Longevity Institute

UNKNOWN

lead

The Neurology Center

OTHER

NCT04202757 - Intravenous Plasma Treatment for Parkinson's Disease | Biotech Hunter | Biotech Hunter